Skip to content
This GLP
Updated September 2026Second month printed up front

MyFastRx review

An introductory first month sits on top of each product page, and the rate for every month after it is printed on the same card.

The verdict

MyFastRx charges $139 a month for compounded semaglutide and $199 for compounded tirzepatide once the first month is over. Both pages lead with a cheaper introductory figure, but they say in the same line what the second month costs, which spares a buyer the surprise that usually arrives with the second charge. The price is also stated to stay flat at every dose, so the months of titration should not move it either.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
Dose pricing
Flat across doses
States
50
From
From $139/mo
Prescription
Required
Compounded
Yes — not FDA-approved
Pharmacy
Not named

MyFastRx is a cash-pay telehealth service selling compounded semaglutide and compounded tirzepatide as weekly injections, with an NAD+ line alongside them. Each molecule has its own product page carrying the introductory month, the standing rate and three prepaid terms in a single row of cards. Insurance is not accepted, and the price is described as including the provider review, the medication and express shipping.

  1. Who writes the prescription, and what do they see?

    A short online intake goes to a licensed U.S. provider, who the site says reviews it within 24 hours and prescribes only when treatment is medically appropriate. The consultation is described as always included at no extra charge. No clinician, medical group or medical director is named on either product page, and what the provider sees beyond the intake answers is not described.

    The pages promise unlimited access to the clinical team for dosage adjustments and questions, and name that support as free. Medication ships from a U.S.-licensed pharmacy in unmarked packaging, usually Monday through Thursday so a cold package does not sit over a weekend. The introductory card says there is no subscription or automatic billing, and the footer adds that a patient cancels before the next shipment.

  2. What happens when the dose goes up?

    The seller's answer to the fourth-month question is written in plain terms: the price does not change from the first week to the sixth month and after, and there are no dosage upcharges. Its FAQ adds that a provider reviews progress before any dose change and that an approved change costs nothing extra. How often that review happens, and what a patient reports into it, is not stated, which leaves the clinical half of each step unexplained.

  3. What the price includes

    Semaglutide opens at $69 for a new customer's first month with code MY70, and the same card says the rate becomes $139 a month after that. Three months prepaid is $297, six is $534 and twelve is $948, and the page prints each as a monthly equivalent of $99, $89 and $79 beside the upfront total. Tirzepatide follows the same pattern, opening at $129 and then $199 a month, with $498, $894 and $1,488 for the three prepaid terms.

  4. What it claims, and what it cites

    Both lines are compounded, and each product page marks them as not FDA-approved. The site says it does not manufacture medication and that prescriptions are filled by U.S.-licensed pharmacies, none of which is named. A compounded preparation is not reviewed by the FDA before it is dispensed.

Where it holds up, and where it does not

  • Strength: Standing rate printed beside the intro month
  • Strength: Price stated as flat at every dose
  • Strength: Dose changes stated to cost nothing extra
  • Strength: Each prepaid term shows its full upfront charge
  • Limitation: The headline figure covers one month only
  • Limitation: No prescriber or medical group is named
  • Limitation: The dispensing pharmacy is not named
  • Limitation: A year of tirzepatide costs $1,488 at once

What the evidence says about this kind of treatment

The assessment above is about MyFastRx. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A buyer who wants to know what the second month costs before starting the first.
Wrong for
A buyer who reads the introductory figure as the ongoing monthly price.

How MyFastRx compares

SellerWho it suitsGo
VoxyReaders who want check-ins included and will pick a cadence deliberatelySee Voxy
Yucca HealthBuyers who want the whole ladder visible before intake and may not stay six monthsSee Yucca Health
Zappy HealthBuyers comparing a compounded plan against the brand routes on the same catalog pageSee Zappy Health
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: CoraDocCorsica HealthCurexDadVantage Men's HealthDirect MedsDoctorAdam

Sponsored alternative

Bodybuilding Health+

A reader unwilling to prepay a year before seeing how the drug goes

Check Bodybuilding Health+ availability →

Frequently asked

Is $69 the monthly price for semaglutide?
Only for a new customer's first month with code MY70. The same card says the rate is $139 a month after that.
Does the price change when the dose goes up?
No, on the seller's wording. The page rules out dosage upcharges and says an approved dose change costs nothing extra.
How are the longer plans billed?
In full at the start. Semaglutide is $297 for three months, $534 for six and $948 for twelve, and tirzepatide is $498, $894 and $1,488.
Is MyFastRx expensive compared with other GLP-1 telehealth sellers?
MyFastRx publishes a starting figure of $139/mo. Across the 368 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $449 with a median of $189, which puts MyFastRx below the median, toward the cheaper end. The other 20 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Ruth AlvarezOutcomes writer · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from MyFastRx’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.